Nurse Practitioner, Psychiatric/Mental Health · Omaha, NE
NPI
1568827095
Since 2015
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
7101 Newport Ave
Omaha, NE, 68152
Phone (402) 572-2916
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
472 services
Medicare patients, 2024
64
Average age 59
Drug cost, 2024
$819K
3,704 prescriptions
Company payments, 2025
$3,418
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Virginia J Smith was code 99214 (office e&m - established), 292 times for 59 patients. In total Virginia J Smith billed 472 services in 6 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 292 | 59 | $74.19 | $22K |
| 90833 Psychotherapy - Nongroup | Office | 158 | 42 | $42.26 | $6,677 |
| 90792 Psychotherapy - Nongroup | Office | 19 | 19 | $117.18 | $2,226 |
By year: 2022 $30K for 490 services; 2023 $28K for 482 services; 2024 $31K for 472 services.
Medicare prescription drug claims, 2024
In 2024, the drug Virginia J Smith prescribed most often to Medicare patients was Quetiapine Fumarate, with 199 prescriptions and refills. In total Virginia J Smith wrote 3,704 Medicare prescriptions that cost $819K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 199 | 252 | 30 | $2,728 |
| Sertraline Hcl Generic | 198 | 267 | 27 | $1,822 |
| Clonazepam Generic | 149 | 152 | 18 | $1,348 |
| Vilazodone Hcl Generic | 136 | 138 | 20 | $13K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 133 | 170 | 19 | $3,263 |
| Buspirone Hcl Generic | 129 | 159 | 23 | $1,463 |
| Divalproex Sodium Generic | 129 | 130 | 11 | $1,514 |
| Lorazepam Generic | 128 | 139 | 22 | $1,127 |
| Trazodone Hcl Generic | 126 | 167 | 25 | $791 |
| Lamotrigine Generic | 116 | 165 | 21 | $1,094 |
| Alprazolam Generic | 110 | 110 | 13 | $848 |
| Vraylar Cariprazine Hcl | 108 | 108 | Under 11 | $150K |
| Risperidone Generic | 104 | 139 | 11 | $1,662 |
| Clomipramine Hcl Generic | 100 | 104 | 13 | $21K |
| Prazosin Hcl Generic | 98 | 102 | Under 11 | $1,280 |
Brand drugs: 400 claims; generic drugs: 3,304 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Virginia J Smith $3,418 ($3,418 in general payments such as food, travel and fees) from 18 companies. The largest payer was Alkermes, Inc. with $785.
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. ALKS | 34 | $785 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 26 | $576 |
| Abbvie Inc. ABBV | 26 | $422 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 17 | $340 |
| Harmony Biosciences LLC HRMY | 9 | $204 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $199 |
| Teva Pharmaceuticals USA, Inc. TEVA | 12 | $175 |
| Axsome Therapeutics, Inc. AXSM | 8 | $151 |
| Neurocrine BioSciences, Inc. NBIX | 6 | $114 |
| Vanda Pharmaceuticals Inc. VNDA | 4 | $101 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.